Navigation Links
Dong-A PharmTech Signs Licensing Deal With Otechestvennye to Market Zydena in Russia
Date:10/15/2007

SEOUL, South Korea, Oct. 15 /PRNewswire/ -- Dong-A PharmTech Co. Ltd announced today the signing of a five-year US$50 Million contract with Otechestvennye Lekarstva OJSC, to market in Russia Dong-A's erectile dysfunction drug which is currently sold in Korea under the brand name of Zydena.

Under the terms of the agreement, Otechestvennye Lekarstva OJSC, one of the largest Russian pharmaceutical firms, will pay both upfront fees and running royalty on sales for the life of the contract. This deal represents the second significant licensing deal for Dong-A, surpassing the contract signed last October with SCP Corp. (Saudi Arabia) for marketing in Gulf Cooperation Council territories

On the strength of Zydena's excellent efficacy and safety profile, Otechestvennye Lekarstva OJSC will make a significant investment in marketing and promoting to Russian physicians. Zydena is distinguished by its long duration of action and low incidence of unfavorable side effects such as vision disturbances and muscle pain. Zydena expects to achieve a market in excess of 20% in Korea in 2007, its second year of sale.

Mr. Dong Hyun Park, president of Dong-A PharmTech stated that "We are extremely pleased to have Otechestvennye as our partner in Russia. The deal with Otechestvennye Lekarstva OJSC positions Zydena for solid sales in the rapidly evolving pharmaceutical market in Eastern Europe and furthers our strategy for marketing Zydena in numerous key countries in Asia, and Latin & South American in advance of our entry into North America and the European Union."

Zydena has a strong intellectual property position with more patents in more than 30 countries. Dong-A PharmTech successfully completed its phase 2 clinical programs in the USA for erectile dysfunction and will proceed to completing all clinical studies required for filing a New Drug Application in the USA and Europe.

Dong-A PharmTech expects to increase global marketability of Zydena by deve
'/>"/>

SOURCE Dong-A PharmTech
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Filtration treatment assigns more live kidney donation
2. Depressed women show signs of earlier onset of Perimenopause
3. More signs to an approaching migraine attack
4. An Indian Bride with signs of SARS
5. Recognize Heart Attack Signs
6. Parents Should Look For Signs Of Children Becoming Overweight
7. Early Warning Signs Of Heart Disease
8. Warning Signs On Powered Baby Milk
9. Genetical Screening Can Detect Early Signs Of Multiple Sclerosis
10. Diagnosis of Alzheimers years before clinical signs emerge
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
Breaking Medicine News(10 mins):Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
...nsible Medicine (PCRM) has developed an in-house a...the insulin level,// which is being marketed by Li...ment of the test kit during the year 2002 amid var...nd the cost and accuracy is not found to vary from...
...l study it has been found that young adults are no...ood. // This is the analysis based on a 10 year... health is better in middle-aged to older adults o... for two decades. "However, the decline is not...
...bout the health benefits of nuts but now there is ...ack a nutritional wallop — at least when eaten in ...inistration has allowed labels for most nuts to sa...ng with nuts, avocados and olive oil was more effe...
...S. Zubenko, MD, PhD, Professor of Psychiatry and B... School reported that genes relating to aging with... This research was the first of its kind and wa... men and women in the study. These individuals sho...
...ed as a wonder drug that can take care of everythi...as now emerged that it can also induce cancer cell...iversity of Pittsburgh report in the December 9 is...ecrosis factor-related apoptosis-inducing ligand (...
...ress called on Monday for more rigorous federal mo... The Food and Drug Administration (FDA) has been m...ut significant gaps remain, according to Rep. Rosa...eved to serve hospitals in all 50 states and at le...
Other Medicine News:Health News:Genetics of Ageing with Preserved Mental Capacity. 2Health News:Aspirin induces Cancer Cells To Commit Suicide 2Health News:Scrutiny Sought For Reused Devices in U.S. 2
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced today that the US Patent and Trademark Office has allowed its patent application o
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Saving Lives Is a Growth Industry 55875 1Saving Lives Is a Growth Industry 55875 2Saving Lives Is a Growth Industry 55875 3China Kangtai Cactus Biotech to Launch Patented Cactus based Low Tar Low or Zero Nicotine Cigarettes 13772 1China Kangtai Cactus Biotech to Launch Patented Cactus based Low Tar Low or Zero Nicotine Cigarettes 13772 2China Kangtai Cactus Biotech to Launch Patented Cactus based Low Tar Low or Zero Nicotine Cigarettes 13772 3Studies in animals suggest 2009 H1N1 virus may have biological advantage over seasonal influenza 55873 1Studies in animals suggest 2009 H1N1 virus may have biological advantage over seasonal influenza 55873 2
Osher Haptic Forceps
Arruga Curved Capsule Forceps
Osher Capsule-Foreign Body Forceps
Tennant Curved Tying Forceps
Medicine Products: